GROWTH-HORMONE (GH) RESPONSIVENESS TO COMBINED ADMINISTRATION OF ARGININE AND GH-RELEASING HORMONE DOES NOT VARY WITH AGE IN MAN

At present, the mechanism(s) underlying the reduced spontaneous and stimulated GH secretion in aging is still unclear. To obtain new information on this mechanism(s), the GH responses to both single and combined administration of GH-releasing hormone (GHRH; 1 μg/kg iv) and arginine (ARG; 30 g infused over 30 min), a well known GH secretagogue probably acting via inhibition of hypothalamic somatostatin release, were studied in seven elderly normal subjects and seven young healthy subjects. Basal GH levels were similar in both groups, while insulinlike growth factor/I levels were lower in elderly subjects (76.7 ± 9.2 vs. 258.3 ± 29.2 μg/L; P = 0.01). In aged subjects GHRH induced a GH increase (area under the curve, 314.9 ± 91.9 ng/L·h) which was lower (P = 0.01) than that in young subjects (709.1 ± 114.4 Mg/Lh). On the other hand, the ARG-induced GH increase in the elderly was not significantly different from that in young subjects (372.8 ± 81.8 vs. 470.6 ± 126.5 μg/L·h). ARG potentiated GH responsiveness to GHRH in both elderly (1787.1 ± 226.0 Mg/L·h; P = 0.0001 vs. GHRH alone) and young subjects (2113.0 ± 444.3 Mg/L·h; P = 0.001 vs. GHRH alone). The potentiating effect of ARG on the GHRH-induced GH response was greater in elderly than in young subjects (1013.0 ± 553.5% vs. 237.9 ± 79.1%; P = 0.0001); thus, the GH increase induced by combined administration of ARG and GHRH overlapped in two groups. In conclusion, these results show that, differently from the GHRH-induced GH increase, the somatotroph response to combined administration of ARG and GHRH does not vary with age. Our finding suggests that an increased somatostatinergic activity may underlie the reduced GH secretion in normal aging. © 1990 by The Endocrine Society.